Positive Phase 3 Topline Results for Migraine Prevention Drug Positive Phase 3 Topline Results for Migraine Prevention Drug

Topline results from the phase 3 ADVANCE trial show that all three doses evaluated of the novel CGRP medication atogepant met the primary endpoint of reduced monthly migraine days.Medscape Medical News

Source: Medscape Internal Medicine Headlines - July 30, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news